Skip to content

The Protocol of a randomized controlled trial of transperitoneal laparoscopic adrenalectomy and retropetoneal laparoscopic adrenalectomy in the treatment of adrenal tumor

The Protocol of a randomized controlled trial of transperitoneal laparoscopic adrenalectomy and retropetoneal laparoscopic adrenalectomy in the treatment of adrenal tumor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070707
Enrollment
Unknown
Registered
2023-04-20
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal tumor

Interventions

Interventions group:retropetoneal laparoscopic adrenalectomy
Control group:transperitoneal laparoscopic adrenalectomy

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients and his families who volunteered to participate this study. And Patient is informed and has given written informed consent. 2.18 years of age and less than 80 years of age, both men and women; 3.Preoperative diagnosis is adrenal tumor by abdominal plain scan or enhanced CT or MRI before surgery, including adrenal cortical tumor, myelolipoma, single metastatic adrenal tumor, etc; 4.Imaging showed that the maximum diameter of the tumor was less than 6cm; 5.Patients who completed adrenal surgery without obvious contraindications after improving relevant tests before surgery.

Exclusion criteria

Exclusion criteria: 1.Patients with distant metastasis or tumor invasion of renal vein and inferior vena cava before surgery; 2.Do not have capable or behavioral capacity is limited; 3.Preoperative routine chest X-ray and pelvic enhancement CT examination revealed that there were no radical surgical procedures or intraoperative exploration in distant metastasis. 4.Surgery combined with other organ resection or laparoscopic surgery transfer to open surgery; 5.Have other serious diseases, including cardiovascular, respiratory, kidney, or liver diseases, and combine to control patients with poor hypertension and diabetes; 6.Pregnant and lactating women; 7.History of abdominal surgery or retroperitoneal surgery or surgery history; 8.Preoperative history of chemotherapy; 9.Severe coagulation function abnormal electrolyte balance disorder hypoproteinemia was corrected without obvious improvement; 10.The researcher considers that there are any other circumstances that are not suitable for participating in the test.

Design outcomes

Primary

MeasureTime frame
Laparoscopic operation time ;Surgical bleeding;

Secondary

MeasureTime frame
Stamp establishment completion time;Overall operation time;Blood transfusion;The number of Trocar and intraoperative additional Trocar; Intraoperative complications;Postoperative drainage fluid;Postoperative ventilation time;Postoperative drain tube placement time;Postoperative hospital stay;Time of postoperative antibiotic application;Postoperative short-term complications;

Countries

China

Contacts

Public ContactShang Panfeng

Lanzhou University Second Hospital

shangpf@lzu.edu.cn+86 13919785295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026